Mangalam Drugs Board Meeting on Aug 12 to Approve Q1 FY27 Results

Mangalam Drugs & Organics Ltd has announced a Board of Directors meeting scheduled for August 12, 2026. The primary agenda is to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2026. Additionally, the board will discuss the appointment of M/s L.N. Joshi & Co. as Secretarial Auditors for five years and M/s S.N. Nanda & Co. as Statutory Auditors. The trading window for dealing in the company's securities has been closed from July 1, 2026, until 48 hours after the announcement of the Q1 FY27 results.